Literature DB >> 8762015

Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts.

U Heemann1, H Azuma, P Hamar, C Schmid, N Tilney, T Philipp.   

Abstract

Mycophenolate mofetil (MMF) interacts with purine metabolism and possibly with the expression of adhesion molecules. In the present study, we analysed the expression of these molecules in transplanted kidney allografts treated with RS LBNF1 kidneys were orthotopically transplanted into Lewis rats and either treated with RS (20 mg/kg/day) or vehicle. Rats were harvested 3, 5 and 7 days following transplantation. For binding studies, fresh-frozen sections of transplanted kidneys were incubated with lymph node lymphocytes (LNL) derived from transplanted rats. Additionally, immunohistology was performed with various monoclonal antibodies. In general, MMF resulted in better preservation of graft structure by 7 days. Cellular infiltration and tubular atrophy were less pronounced. At day 3, macrophages were diminished in MMF-treated animals to a high extent, while the number of T cells was almost identical to that of controls. In addition, the number of cells positive for MHC class II and LFA-1 was reduced in the MMF-treated animals. These findings correlated with the binding results. Three days following engraftment, LNL bound to MMF-treated kidneys to a lesser extent compared to controls. In conclusion, MMF resulted in a markedly reduced leucocytic infiltrate, presumably based on a reduced expression of lymphocytic adhesion molecules and an interaction with macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762015     DOI: 10.1016/s0966-3274(96)80039-6

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  10 in total

1.  Mycophenolate mofetil prevents cerebrovascular injury in stroke-prone spontaneously hypertensive rats.

Authors:  Isha S Dhande; Yaming Zhu; Michael C Braun; M John Hicks; Scott E Wenderfer; Peter A Doris
Journal:  Physiol Genomics       Date:  2016-12-23       Impact factor: 3.107

Review 2.  Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Authors:  Javier Bueno; Carmen Ramil; Michael Green
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

Authors:  Jodi L Karnell; Fredrick G Karnell; Geoffrey L Stephens; Bhargavi Rajan; Chris Morehouse; Ying Li; Bonnie Swerdlow; Mildred Wilson; Raphaela Goldbach-Mansky; Christopher Groves; Anthony J Coyle; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

4.  Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder.

Authors:  Jie Lin; Binbin Xue; Jia Li; Ruofan Zhu; Juyuan Pan; Zhibo Chen; Xu Zhang; Xiang Li; Junhui Xia
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

5.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

6.  Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice.

Authors:  Elaine T Long; Stephanie Baker; Vanessa Oliveira; Birgit Sawitzki; Kathryn J Wood
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

7.  The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.

Authors:  K Leckel; W-D Beecken; D Jonas; E Oppermann; M C Coman; K-F Beck; J Cinatl; N P Hailer; M K H Auth; W O Bechstein; M Shipkova; R A Blaheta
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

8.  Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy.

Authors:  Tobias Engl; Jasmina Makarević; Borna Relja; Iyad Natsheh; Iris Müller; Wolf-Dietrich Beecken; Dietger Jonas; Roman A Blaheta
Journal:  BMC Cancer       Date:  2005-01-11       Impact factor: 4.430

9.  Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.

Authors:  Ben Sprangers; Vinay Nair; Vincent Launay-Vacher; Leonardo V Riella; Kenar D Jhaveri
Journal:  Clin Kidney J       Date:  2017-10-27

10.  Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation.

Authors:  Jiexin Zhang; Xian Chen; Guodong Rong; Ting Xu; Hong Zhao; Dan Chen; Lei Wu; Peijun Huang; Fang Wang
Journal:  Onco Targets Ther       Date:  2018-08-24       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.